Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Dextrine Gr. I Yellow As Per Is 4269 1981 With Following Terms 1. Material Should Be Supplied In Mo
|
| Description |
|
| Organisation | Department of Defence Production | Ministry of Defence |
| Tender Id | GEM/2025/B/6335743 |
|
Reference Number |
- |
| Tender Fee | - |
| EMD | - |
| Tender Value | - |
| Place | |
| Link |
View Original Tender Notice
https://bidplus.gem.gov.in/all-bids |
| Start Date | June 12, 2025 16:42 |
| End Date |
Expired
03/07/2025
Expired 469 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Award of Contract & Bid Results
Tender Status:
active
Ministry:
Ministry Of Defence
Department:
Department Of Defence Production
Organisation:
Yantra India Limited
Similar Tenders
Dextrine gr. i yellow as per is-4269-1981 with following terms 1. material should be supplied in mo
Dextrine gr. i yellow as per is-4269-1981 with following terms 1. material should be supplied in mo
Read moreDextrin as per is: 4269-1981 grade 1 yellow. packing: to be supplied in pouch of 02kg only. pouches
Read more
(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
Read more(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
Read more
Click
Here to Download Dockets
of your Industry type
of your Industry type